Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 2 (2005), Issue 8 (August)

1. Automatic detection of movement disorders using recordings of rapid alternating movements.
   J Neurosci Methods, 146(2): 183-90. [Abstract] [Full-text]
2. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
   Life Sci, 77(15): 1836-43. [Abstract] [Full-text]
3. Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?
   Mov Disord, 20(8): 1060-2. [Abstract] [Full-text]
4. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
   Mov Disord, 20(8): 976-81. [Abstract] [Full-text]
5. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
   Mov Disord, 20(8): 1021-30. [Abstract] [Full-text]
6. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation.
   Mov Disord, 20(8): 1052-5. [Abstract] [Full-text]
7. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom.
   Mov Disord, 20(8): 995-8. [Abstract] [Full-text]
8. Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease?
   Mov Disord, 20(8): 1066-9. [Abstract] [Full-text]
9. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
   Mov Disord, 20(8): 989-94. [Abstract] [Full-text]
10. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
    Mov Disord, 20(8): 1031-3. [Abstract] [Full-text]
11. Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease.
    Mov Disord, 20(8): 971-5. [Abstract] [Full-text]
12. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data.
    Mov Disord, 20(8): 964-70. [Abstract] [Full-text]
13. Characterization of subclinical tremor in Parkinson's disease.
    Mov Disord, 20(8): 945-50. [Abstract] [Full-text]
14. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia.
    Mov Disord, 20(8): 999-1005. [Abstract] [Full-text]
15. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
    Mov Disord, 20(8): 958-63. [Abstract] [Full-text]
16. Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.
    Mov Disord, 20(8): 932-6. [Abstract] [Full-text]
17. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease.
    J Biol Chem, 280(32): 29194-8. [Abstract] [Full-text]
18. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study.
    Arch Neurol, 62(8): 1265-9. [Abstract] [Full-text]
19. Sudden uncontrollable somnolence and medication use in Parkinson disease.
    Arch Neurol, 62(8): 1242-8. [Abstract] [Full-text]
20. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
    Eur Neurol, 53(4): 197-202. [Abstract] [Full-text]
21. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Brain Res, 1053(1): 10-8. [Abstract] [Full-text]
22. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
    Exp Neurol, 195(1): 27-39. [Abstract] [Full-text]
23. Speech motor programming in hypokinetic and ataxic dysarthria.
    Brain Lang, 94(3): 347-66. [Abstract] [Full-text]
24. Past tense formation and comprehension of passive sentences in Parkinson's disease: evidence from Greek.
    Brain Lang, 94(3): 297-303. [Abstract] [Full-text]
25. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    J Mol Biol, 351(5): 1081-100. [Abstract] [Full-text]
26. Nosology of Parkinson's disease: looking for the way out of a quagmire.
    Neuron, 47(4): 479-82. [Abstract] [Full-text]
27. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Eur J Neurosci, 22(3): 735-44. [Abstract] [Full-text]
28. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile.
    Helicobacter, 10(4): 288-97. [Abstract] [Full-text]
29. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study.
    Helicobacter, 10(4): 276-87. [Abstract] [Full-text]
30. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism.
    Helicobacter, 10(4): 267-75. [Abstract] [Full-text]
31. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.
    J Neurol Neurosurg Psychiatry, 76(9): 1217-21. [Abstract] [Full-text]
32. How useful is [123I]beta-CIT SPECT in clinical practice?
    J Neurol Neurosurg Psychiatry, 76(9): 1211-6. [Abstract] [Full-text]
33. Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 76(9): 1204-10. [Abstract] [Full-text]
34. The effect of deep brain stimulation on quality of life in movement disorders.
    J Neurol Neurosurg Psychiatry, 76(9): 1188-93. [Abstract] [Full-text]
35. Dimensions of executive function in Parkinson's disease.
    Dement Geriatr Cogn Disord, 20(2): 140-4. [Abstract] [Full-text]
36. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Hum Mol Genet, 14(17): 2571-86. [Abstract] [Full-text]
37. Parkinsonian voice acoustic analysis in real-time after stereotactic thalamotomy.
    Stereotact Funct Neurosurg, 83(2): 115-21. [Abstract] [Full-text]
38. Usefulness of an intraoperative electrophysiological navigator system for subthalamic nucleus surgery in Parkinson's disease.
    Stereotact Funct Neurosurg, 83(2): 101-7. [Abstract] [Full-text]
39. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease.
    Stereotact Funct Neurosurg, 83(2): 80-3. [Abstract] [Full-text]
40. A preliminary study of transient confusional states following bilateral subthalamic stimulation for Parkinson's disease.
    Stereotact Funct Neurosurg, 83(2): 67-70. [Abstract] [Full-text]
41. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.
    Eur J Hum Genet, 13(9): 1086-93. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.